VNRX - VolitionRx slumps on pricing $7.5M in stock offering
- VolitionRx ( NYSE: VNRX ) priced an underwritten public offering of 4.3M shares at a public offering price of $1.75/share; underwriters granted 30-day option to purchase up to an additional 645K shares.
- Gross proceeds re expected to be $7.525M; net proceeds to be used for research and continued product development, clinical studies, product commercialization, working capital and other general corporate purposes, including potential strategic acquisitions.
- Offering is expected to close on or about Feb.22, 2023.
- Shares trading 15.2% down premarket.
For further details see:
VolitionRx slumps on pricing $7.5M in stock offering